Side Effects of Chloroquine and Primaquine and Symptom Reduction in Malaria Endemic Area (Mâncio Lima, Acre, Brazil)
- PMID: 26357512
- PMCID: PMC4556080
- DOI: 10.1155/2015/346853
Side Effects of Chloroquine and Primaquine and Symptom Reduction in Malaria Endemic Area (Mâncio Lima, Acre, Brazil)
Abstract
Side effects of antimalarial drug can overlap with malaria symptoms. We evaluated 50 patients with vivax malaria in Mâncio Lima, Acre, treated with chloroquine and primaquine. Patients were evaluated for the presence of 21 symptoms before and after treatment and for reported side effects of these drugs after treatment was started. The most frequent symptoms before medication were headache, fever, chills, sweating, arthralgia, back pain, and weakness, which were present in between 40% and 76% of respondents. The treatment reduced the occurrence of these symptoms and reduced the lack of appetite, but gastrointestinal symptoms and choluria increased in frequency. There were no reports of pale stools before medication, but 12% reported the occurrence of this symptom after treatment started. Other symptoms such as blurred vision (54%), pruritus (22%), paresthesia (6%), insomnia (46%), and "stings" into the skin (22%) were reported after chloroquine was taken. The antimalarial drugs used to treat P. vivax malaria reduce much of the systemic and algic symptoms but cause mainly gastrointestinal side effects that may lead to lack of adherence to drug treatment. It is important to guide the patient for the appearance and the transience of such side effects in order to avoid abandoning treatment.
Similar articles
-
Vector competence, vectorial capacity of Nyssorhynchus darlingi and the basic reproduction number of Plasmodium vivax in agricultural settlements in the Amazonian Region of Brazil.Malar J. 2019 Apr 4;18(1):117. doi: 10.1186/s12936-019-2753-7. Malar J. 2019. PMID: 30947726 Free PMC article.
-
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine.Malar J. 2019 Sep 23;18(1):325. doi: 10.1186/s12936-019-2950-4. Malar J. 2019. PMID: 31547827 Free PMC article. Clinical Trial.
-
Safety, efficacy and pharmacokinetic evaluations of a new coated chloroquine tablet in a single-arm open-label non-comparative trial in Brazil: a step towards a user-friendly malaria vivax treatment.Malar J. 2016 Sep 17;15:477. doi: 10.1186/s12936-016-1530-0. Malar J. 2016. PMID: 27639847 Free PMC article. Clinical Trial.
-
Primaquine for preventing relapses in people with Plasmodium vivax malaria.Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004389. doi: 10.1002/14651858.CD004389.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2013 Oct 26;(10):CD004389. doi: 10.1002/14651858.CD004389.pub3. PMID: 17253504 Updated. Review.
-
The treatment of malaria.N Engl J Med. 1996 Sep 12;335(11):800-6. doi: 10.1056/NEJM199609123351107. N Engl J Med. 1996. PMID: 8703186 Review.
Cited by
-
N-(coumarin-3-yl)cinnamamide Promotes Immunomodulatory, Neuroprotective, and Lung Function-Preserving Effects during Severe Malaria.Pharmaceuticals (Basel). 2023 Dec 27;17(1):46. doi: 10.3390/ph17010046. Pharmaceuticals (Basel). 2023. PMID: 38256880 Free PMC article.
-
Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis.J King Saud Univ Sci. 2020 Oct;32(7):3159-3166. doi: 10.1016/j.jksus.2020.09.002. Epub 2020 Sep 6. J King Saud Univ Sci. 2020. PMID: 32921965 Free PMC article.
-
Acute chloroquine and hydroxychloroquine toxicity: A review for emergency clinicians.Am J Emerg Med. 2020 Oct;38(10):2209-2217. doi: 10.1016/j.ajem.2020.07.030. Epub 2020 Jul 19. Am J Emerg Med. 2020. PMID: 33071096 Free PMC article. Review.
-
Therapeutic efficacy of Chloroquine for the treatment of uncomplicated Plasmodium vivax infection in Shewa Robit, Northeast Ethiopia.PLoS One. 2023 Jan 12;18(1):e0277362. doi: 10.1371/journal.pone.0277362. eCollection 2023. PLoS One. 2023. PMID: 36634046 Free PMC article.
-
Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics.J Mol Model. 2018 Jul 28;24(8):220. doi: 10.1007/s00894-018-3746-0. J Mol Model. 2018. PMID: 30056475
References
-
- Hindi P. World Malaria Report 2010. 2010. http://www.who.int/malaria/world_malaria_report_2010/en/
LinkOut - more resources
Full Text Sources
Other Literature Sources